Introduction
Tuberculosis is mostly transmitted through air by infected persons coughing, sneezing or spiting with pulmonary tuberculosis. The probability of transmission per contact, per relevant unit time is general quite low. The bacteria may lodge in the person's lung and multiply. If the immune system in the lung is able to fight the bacteria and render it inactive (wall off) as a result of vaccination or treatment from TB, the person will develop latent TB which is not infectious and cannot harm others.
Infected individuals may remain asymptomatic over their entire live (Latent TB). Active TB (the clinical disease) can develop into pulmonary and extra pulmonary form. Extra pulmonary TB is common in children while pulmonary TB is frequent in adult. Mycobacterium tuberculosis, the casual agent of the disease is transmitted almost exclusively via pulmonary cases. Cases arising within Five (5) years from first infection are classified as primary tuberculosis while cases arising after five (5) years from first infection are known as secondary tuberculosis. The asymptomatic individual may remain at latent for a long period of time due to vaccine durations and the antibody defense deposit in the body unless cured by treatment with antibiotics such as Ethanbutol, Rifanpacine, B6 e.t.c. if the bacteria later become active due to breakdown of the immune system, the person is symptomatic and infectious and can be cured (recovered) if treated otherwise die from the infection.
The person when cured becomes susceptible as he is likely to be re-infected on contact with an infected person. Recent research efforts have been geared towards studying the heterogeneous factors in the population with a view to incorporate them into the model. The efforts that have been made by researchers and their findings on various aspects of TB disease dynamics falls under the following subheadings. i. Transmission ii. Vaccination against tuberculosis iii. Protective efficacy of the vaccine and duration of immunity iv. Infection v. Treatment vi. Prevention
Most early transmission models were deterministic but recent resurgence of tuberculosis (TB) in develop countries and increase in cases of casualty contact and public transport suggested a model based on thorough understanding of the dynamics of the disease.
Castillo-Chavez and Feng (1998) also consider an age-structured model, in this case with agedependent transmission rates. They include one form of latency, as in their earlier work, and this model does not contain re-infection. They study vaccination, and define a vaccine-dependent 0 R threshold R ( ). They prove stability of the disease-free equilibrium when R ( ) < 1, and the existence of an endemic steady state when R(  ) > 1, and discuss analytically-determined optimal vaccination strategies. These turn out to be either vaccination at a single age, or vaccination in precisely two age classes. Aparacio et al (2000) develop a generalized household model, which took close and casual contact into account. The house cluster comprises of social networks (Family member, office mates, classmates, any person who have prolong contact with an active case). The basic reproductive number for the model is
Where  the transmission rate, n is the size of the cluster,  natural mortality rate,  the total percapita removal rate from infected and k is the progression rate to active TB. BCG-induced immunity develops about six weeks after vaccination. Experimental studies indicate that the mechanism of protection by BCG vaccination consists in reduction of the hematogenous spread of bacilli from the site of primary infection Smith & Harding (1979) mediated by memory T lymphocytes induced by the first exposure to BCG. There is no evidence that BCG reduces the risk of becoming infected with tuberculosis bacilli, but it prevents forms of tuberculosis depending on hematogenous spread of the bacillus Heimbeck (1929) . This inhibition of the hematogenous spread of bacilli thus reduces the risk of immediate disease and of disease due to reactivation. Because there is reduction in risk of immediate disease, but not of infection, there is a difference in the protective effect of BCG, depending on the type of tuberculosis infection. Myint et al. (1987) . The best method for determining the protective efficacy of a vaccine is a prospective, randomized, double-blind, placebo-controlled trial. These studies are difficult and expensive, and have rarely been performed. WHO has recently sponsored studies to evaluate the protective efficacy of BCG immunization in infants and/or children by two low-cost methods: case-control studies Smith (1982 Smith ( , 1987 and contact studies Ten Dam (1987) .
These studies have recently been reviewed by Milstien and Gibson (1989) , who concluded that there is good evidence that the efficacy of modern BCG vaccines is in the range of 60% to 90% for disseminated tuberculosis or meningitis in young children, but somewhat lower for other forms of primary tuberculosis disease. They also found no evidence that one BCG preparation tested was more efficacious than any other under the conditions of the trials, and thus no evidence to support the choice of one preparation or manufacturer of BCG over another on the basis of protective efficacy. A recent matched case-control study in Bangkok Sirinavin et al. (1991) found an adjusted protective efficacy for neonatal BCG vaccination of 83%, and provided evidence to support the thesis that the accuracy of tuberculosis diagnosis, the types of tuberculosis, the length of time after vaccination, and the household tuberculosis exposure contribute to variation in the reported protective efficacy of neonatal BCG vaccination. There is a need for the development of a single in vitro test capable of predicting the induction of immune resistance of humans to infection or dissemination of M. tuberculosis. Despite the difficulty in interpretation of data, several trials have shown that efficacy of BCG is highest among the youngest recipients, and that it falls with increasing age at vaccination Fine et al. Tuberculosis Prevention Trial (1979) .
It is therefore difficult to assess the impact of BCG vaccination programmes. However, when BCG immunization of newborns was stopped in Sweden, the incidence of the disease in infants raised six fold Romanus (1987) . There are several publications which suggest that the protection BCG provides against tuberculosis is a function of the relative importance of disease due to endogenous reactivation as compared to re infection from the outside. Thus, BCG protects against hematogenous spread of infection Fine (1988) , Ten Dam (1984) . This suggestion predicts the greater protective efficacy seen against miliary tuberculosis and tuberulous meningitis, compared with pulmonary tuberculosis Smith (1987) .
II.

Prevention and Control for Tuberculosis
Dye et al (1998) also have developed an age-structured model, with the goal of exploring TB control under the DOTS strategy and under improved case detection and cure. Their model uses discrete time rather than a partial differential equation framework. It includes two latent classes (slow and fast) with a set portion of new infections moving into each, as well as re-infection. They validate their model by comparing their results to annual risk of infection data from the Netherland. They then simulate different epidemiological situations. They conclude that if tuberculosis is stable, and if HIV is not included in the model, then WHO targets of 70% case detection and 85% cure "would reduce the incidence rate by 11% (range 8-12) per year and the death rate by 12% (9-13) per year". The effect would be smaller if TB were already in decline. They conclude that DOTS has greater potential today (in developing countries) than it did 50 years ago in developed countries, but that case detection and cure rates must be improved. Salomon et al. (2006) extend this model, calibrating it to natural TB epidemics and then studying the effects of hypothetical new treatments with differing durations. In their model, drug resistance could result from transmission and acquisition. They first calibrate the model to represent TB in South-East Asia. They conclude that if more rapid treatments for TB were available, with reduced infectious periods, this could significantly reduce TB mortality and incidence, particularly if these become available soon.
There are, of course, other alternatively-structured models. Salpeter and Salpeter (1998) used TB incidence data to derive a function for the time delay from initial infection to active disease, and develop an integral equation for 0 R .This is not a dynamic epidemiological model for TB, but it is relevant to TB models because the variable delays and widely ranging estimates of 0 R are important. They report 0 R near 1, which was associated with time scales of approximately 100 years.
III. Model Formulation
The model is going to divided into four classes of population under study namely; i. The passively immune infant ii. Susceptible Class iii. Infected Class Iv. Recovery Class Based on this, the researchers divided the populations into four compartments represented as: Model Diagram 
Disease Free Equilibrium (DFE)
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Epidemic Equilibrium State (EE)
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Hence, the Epidemic Equilibrium (EE) states are as follows:
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Disease Free Stability Analysis
The characteristic equation above takes the form: 23) is applied to the characteristic equation (18) . We consider (18) in the form ( ) 0 H   And we obtain: 
Stability Analysis of the Epidemic Equilibrium
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Results and Discussion
Data collected from Tuberculosis and Leprosy unit, Ministry of Health, Taraba state, Nigeria, was used to obtain the simulation for the model.
Using hypothetical values pertinent to Taraba State, the researchers obtain the following results using Maple software as shown below: 
Simulations
The first example is concern with the estimation properties of the VSIR model given by equation ( 
VI. Conclusion
Conclusively, we will like to conclude that, Progression to active TB among the population is epidemiologically significant and interventions should focus on both vaccinations and treatment of infected persons, therefore, effort should be made to minimize the contraction rate for the sustenance of North Senatorial Zone of Taraba state. Anti-tuberculosis, treatment of adults is crucial in controlling the epidemic and intervention measures such as frequent vaccination and adhering to TB treatment should be proposed and implemented, they should target progression to active TB for those infected.
Recommendations:
Tuberculosis is an airborne disease and therefore prevention and control of tuberculosis could be achieved if the following measures are adopted: 
